Cite

    Lara Lacerda et al.. “Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.” Breast cancer research, vol. 17, no. 1, 2015, pp. 1–17. http://access.bl.uk/ark:/81055/vdc_100081061168.0x00013e